EHR-based Thromboembolism Risk Tools Boosts Prophylaxis : vi

A clinical decision-support tool designed to identify hospitalized patients in need of VTE prophylaxis cut the rate of thromboembolism at 30 days in the randomized IMPROVE-DD VTE trial.

Related Keywords

Boston , Massachusetts , United States , New York , Boston University , Chicago , Illinois , American , Alexc Spyropoulos , Elainem Hylek , Gregory Piazza , American Heart Association , Northwell Health , Agency For Healthcare Research , More Detail , Healthcare Research , Thromboembolism , Healthcare Technology , Ealth Care Technology , Hospitals , Prophylaxis , Electronic Medical Record Emr , Electronic Medical Record , Omputerized Medical Records Systems , Mr , Anticoagulation Therapy , Anticoagulant , Anticoagulation , Atrial Fibrillation , F Atrial Fibrillation , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc4 ,